Research Paper Volume 13, Issue 17 pp 21385—21399

Identification and validation of a ferroptosis-related gene signature predictive of prognosis in breast cancer

Correlation between the signature, mutation status, and drug susceptibilities. (A) somatic mutation count in the high- and low-risk groups. (B) tumor mutation burden (TMB) in the high- and low-risk groups. (C–H) drug susceptibilities in the high- and low-risk groups.

Figure 7. Correlation between the signature, mutation status, and drug susceptibilities. (A) somatic mutation count in the high- and low-risk groups. (B) tumor mutation burden (TMB) in the high- and low-risk groups. (CH) drug susceptibilities in the high- and low-risk groups.